Consolidated Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Consolidated Statements of Operations [Abstract]
Revenue	$ 2,607,000	$ 0
Costs and expenses:
Patient expenses	692,000	0
Selling, general and administrative	1,179,000	994,000
Total	1,871,000	994,000
Operating income (loss)	736,000	(994,000)
Interest expense	(184,000)	(15,000)
Interest income	0	11,000
Gain from sales of investments in unconsolidated entities	237,000	0
Income (loss) from investments in unconsolidated entities	14,000	(31,000)
Income (loss) before income taxes	803,000	(1,029,000)
Provision for income tax (expense) benefit	(242,000)	362,000
Net income (loss)	$ 561,000	$ (667,000)
Basic and diluted net income (loss) per share	$ 0.07	$ (0.09)
Weighted average common shares outstanding (in shares)	7,797,185	7,797,185